&lt;i&gt;NFE2L2&lt;/i&gt;-Associated Ferroptosis Resistance Reshapes the Tumor Immune Microenvironment and Guides Therapeutic Strategies in Prostate Cancer. The gene discussed is NFE2L2; the disease is prostate carcinoma.